期刊文献+

甲状腺乳头状癌细胞线粒体DNAD环区的突变 被引量:2

Somatic mutations of mitochondrial DNA in thyroid papillary carcinoma
原文传递
导出
摘要 目的研究线粒体 DNA D 环(D-loop)区在甲状腺乳头状癌中的突变情况。方法对35例甲状腺乳头状癌患者的癌组织和外周血淋巴细胞抽提线粒体 DNA,再行 PCR 产物直接测序的方法对线粒体 D 环区的两个高变区(HVR-Ⅰ和 HVR-Ⅱ)进行突变检测。结果在35例甲状腺乳头状癌患者中有2例发现突变,突变率为5.7%。突变位点5个,都在 HVR-Ⅱ区,均为同质性突变,其中2个属于微卫星不稳定,其余3个属于碱基替代突变。研究同时发现2个尚未报道的新的多态位点(nt324:C→G,ntl6092:T→A)。结论与其他上皮来源肿瘤相比,线粒体 DNA D 环区在甲状腺乳头状癌中的突变率不高,其与甲状腺乳头状癌发生的关系仍有待于进一步研究。 Objective To analyze the somatic mutations in the D-loop of mtDNA and further evaluate the possibility of mitochondrial genetic instability in thyroid papillary carcinoma. Methods Hypervariable regions ( HVR- I and HVR- Ⅱ ) in the D-loop of mtDNA from the specimen of 35 thyroid papillary cancers and matched lymphocytes were amplified by PCR, and then were sequenced. Results Comparing the sequences of tumors to those of matched lymphocytes and normal thyroid tissues, 5 somatic mutations in 2 patients (5.7%) were found. Two mutations were insertions of C in a poly-cytidine ( nt303 ) microsatellite, and 3 at positions 73, 152 and 194 in HVR-Ⅱ. In addition, of the 294 genetic variants detected, 292 were previously recorded polymorphisms, whereas 2 were new polymorphisms (nt324:C→G, nt16092 :T→A). Conclusions Mutations in the D-loop of mtDNA were found in thyroid papillary cancers, this mutation rate was lower than the reported rate of alteration in tumors of epithelial origin, and further work is required to elucidate the relationship between this mutations and the development of thyroid papillary carcinoma.
出处 《中华耳鼻咽喉头颈外科杂志》 CAS CSCD 北大核心 2006年第10期782-785,共4页 Chinese Journal of Otorhinolaryngology Head and Neck Surgery
基金 国家自然科学基金(30371236)
关键词 甲状腺肿瘤 乳头状 DNA 线粒体 突变 多态性 单核苷酸 Thyroid neoplasms Carcinoma, papillary DNA, mitochondrial Mutation Polymorphism, single nucleotide
  • 相关文献

参考文献17

  • 1Anderson S,Bankier AT,Barrell BG,et al.Sequence and organization of the human mitochondrial genome. Nature, 1981, 290 : 457-465.
  • 2Chomyn A, Attardi G. MtDNA mutations in aging and apoptosis.Biochem Biophys Res Commun,2003, 304: 519-529.
  • 3Mambo E, Chatterjee A, Xing M, et al. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer, 2005,116: 920-924.
  • 4Yeh JJ, Lunetta KL, van Orsouw NJ, et al. Somatic mltochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours.Oncogene, 2000, 19: 2060-2066.
  • 5Rogounovitch TI, Saenko VA, Shlmizu-Yoshida Y, et al. Large deletions in mitochondrial DNA in radiation-associated human thyroid tumors. Cancer Res, 2002, 62: 7031-7041.
  • 6Stoneking M. Hypervariable sites in the mtDNA control region are mutational hotspots. Am J Hum Genet, 2000, 67 : 1029-1032.
  • 7Mazzaferri EL, Kloos RT. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab, 2001, 86:1447-1463.
  • 8Abu-Amero KK, Alzahrani AS, Zou M, et al. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex Ⅰ respiratory defect in thyroid cancer cell lines.Oncogene, 2005, 24: 1455-1460.
  • 9Andrews RM, Kubacka I, Chinnery PF, et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet, 1999, 23 : 147.
  • 10Liu VW, Shi HH, Cheung AN, et al. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas.Cancer Res, 2001, 61 : 5998-6001.

同被引文献24

  • 1韩月臣,孔维佳,张松,王彦君,王莹,陈雄.喉鳞状细胞癌组织中线粒体基因4977bp缺失突变的检测[J].癌症,2004,23(11):1297-1301. 被引量:7
  • 2Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome[J]. Nature, 1981, 290(5806) :457-465.
  • 3Sanehez-Cespedes M, ParreUa P, Nomoto S, et al. Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors[J]. Cancer Res, 2001, 61(19):7015-7019.
  • 4Ha PK, Tong BC, Westra WH, et al. Mitochondrial C- tract alteration in premalignant lesions of the head and neck: A marker for progression and clonal proliferation [J]. Clin Cancer Res, 2002, 8 (7):2260-2265.
  • 5Lievre A, Blons H, Hottllier AM, et al. Clinicopathological. significance of mitochondrial D-Loop mutations in head and neck carcinoma[J]. Br J Cancer, 2006, 94 (5): 692-697.
  • 6Prior SL, Griffiths AP, Baxter JM, et al. Mitochondrial DNA mutations in oral squamous cell carcinoma[J]. Carcinogenesis, 2006, 27 (5) : 945-950.
  • 7Tong BC, Ha PK, Dhir K, et al. Mitochondrial DNA alterations in thyroid cancer[J]. J Surg Oncol, 2003, 82 (3) : 170-173.
  • 8Maximo V, Lima J, Soares P, et aL Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy[J]. Mitochondrion, 2005, 5 (5) : 333-340.
  • 9Lee HC, Yin PH, Yu TN, et al. Accumulation of mitochon- drial DNA deletions in human oral tissues-effects of betel quid chewing and oral cancer[J]. Mutat Res, 2001, 493 (1/2) : 67-74.
  • 10Shao JY, Li YH, Gao HY, et al. High frequency of common deletion(4981 bp) in mitochondrial DNA in nasopharyngeal carcinoma and its correlation with patient age and clinical stages[J]. Cancer Biol Ther, 2004, 3(12):1270-1274.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部